|Articles|August 26, 2014

3M Partners with Premier on Purchasing Agreement for Catheter Securement and Stability Products

3M Critical & Chronic Care Solutions announces that it has reached a group purchasing agreement with healthcare alliance company Premier, Inc. for multiple catheter securement and stability products. In a move aimed at bringing greater economic efficiencies to Premier’s more than 100,000 healthcare provider members, the new agreement allows them to take advantage of special pricing and terms pre-negotiated by Premier. The purchasing contract covers products including Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressings and Tegaderm™ I.V. Advanced Securement Dressings as well as the 3M™ PICC/CVC Securement Device + Tegaderm™ I.V. Advanced Securement Dressing, a sutureless securement system.

“We’ve been very impressed with Premier’s work improving quality health care by facilitating better and more cost-effective patient outcomes,” says Brent Ashton, global business director for 3M Critical & Chronic Care Solutions. “The products covered by this purchasing agreement offer a unique mix of versatility and reliability, applying 3M’s expertise in transparent films and adhesives to improve patient care and safety, clinician confidence and overall cost of care. Collectively, they address the full securement and stability needs of providers and their patients.”

Unlike many of the single-purpose products previously covered by Premier’s purchasing agreement with a competitor, the products included in the new agreement with 3M were designed to accommodate multiple catheter types. For example, the PICC/CVC Securement System accommodates the majority of PICC and short-term CVC catheters with diameters up to and including 12 French, and comes in a single package containing a dressing and a device to simplify product selection. In addition, it uses state-of-the-art 3M technology that not only provides reliable adhesion, but removes more gently from skin than the product it replaces on the Premier contract. This may reduce the need for supplementary products like alcohol that were previously needed to remove the competitor’s products. Providers may not only reduce costs associated with ordering, stocking and training, but may also improve patient care, potentially reducing the number of dressing changes and restarts.

Tegaderm™ CHG Dressings combine the most critical elements of I.V. site care into a single product, offering antimicrobial protection, catheter securement, site visibility and breathability. Tegaderm™ I.V. Advanced Securement Dressings are comprehensively designed to deliver exceptional patient care by providing effective catheter securement, seven day wear time, gentle removal and excellent moisture management. Additionally, the 3M PICC/CVC Securement Device + Tegaderm™ I.V. Advanced Securement Dressing, a sutureless securement system, provides both patient comfort and reliable IV catheter securement that was found to be equally or more effective than competing devices and sutures when evaluated by clinicians in 19 facilities. The system is designed to stay in place for up to seven days, yet removes gently to deliver the reliable adhesion and comfort patients deserve.

Source: 3M Critical & Chronic Care Solutions

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.